Delivery Order SPE2DB22D1106-SPE2DB25FFBA5
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $60,450 to AmerisourceBergen Drug Corp on July 21, 2025, for pharmaceutical products and medical supplies. This firm fixed-price delivery order, which is set to complete by July 22, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award is unclassified as a set-aside procurement, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $34,594.70 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on July 28, 2025, with a completion date of July 29, 2025. This non-competitive, firm fixed-price delivery order represents a fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026. The product will be delivered to...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,260.24 to AmerisourceBergen Drug Corp on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order, issued under a non-competitive, non-set-aside procurement, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The order will be performed at the company's corporate office in Conshohocken, Pennsylvania. As a major...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for supply of HUMIRA (CF) Pen 40 mg/0.4 mls with a ceiling value of $30,231.93. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill the performance...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,963.79 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The delivery order carries no set-aside designation...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,158.40 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,751.04 to AmerisourceBergen Drug Corp on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price, competitively awarded contract (No. 4568924057) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The vendor, headquartered in Conshohocken, Pennsylvania, will perform services at its corporate office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $43,436.25 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX, a $1 billion comprehensive pharmaceutical support vehicle that runs through December 2026. The delivery order represents a child contract under this...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBA5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,613.15 to AmerisourceBergen Drug Corp on August 1, 2025, for 2,400 units of HUMATE-P VWF:RCOS with an ultimate completion date of August 22, 2025. This firm fixed-price, competitively awarded contract represents a non-set-aside delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The company, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order for HUMATE-P, a von Willebrand Factor concentrate, exemplifies the specialized medical commodities supplied under AmerisourceBergen's DLA prime vendor agreement, which encompasses brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The contract demonstrates the company's capability to fulfill federal healthcare procurement requirements through competitive bidding, supporting the Defense Health Agency and other government healthcare systems with essential pharmaceutical products needed for military medical operations and treatment protocols.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 8/1/25 |